NVDA
NVIDIA
-- 147.220 TSLA
Tesla
-- 412.380 AAPL
Apple
-- 223.660 TEM
Tempus AI
-- 54.840 PLTR
Palantir
-- 78.980 
Update
$Eledon Pharmaceuticals (ELDN.US)$ Reuters· 5 mins ago
Eledon Announces Completion of Enrollment in Phase 2 Bestow Clinical Trial Assessing Tegoprubart for Prevention of Organ Rejection in Kidney Transplant Patients
Eledon Announces Completion of Enrollment in Phase 2 Bestow Clinical Trial Assessing Tegoprubart for Prevention of Organ Rejection in Kidney Transplant Patients
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Discussing
Trump 2.0 Era: What's the next opportunity in the markets?
▪️Could Trump's crypto policies potentially benefit the crypto market? ▪️Might his tariff policies have a positive effect on Chinese stocks
Michael McCarthy CCO
Jan 3 11:57
Ask a strategist - Trump's first day